How A Fluke Led Acceleron Pharma To A Crippling Blood Disease
7/18/2014 7:16:26 AM
How maddening is drug development? Sometimes, all the scientific literature in the world leads you one way, and your own data take you another. That’s why even experienced drug hunters often need a little luck to succeed. Just ask longtime industry veteran John Knopf, who had no idea his Cambridge, MA-based Acceleron Pharma, would end up battling a gene therapy company to be first to market with an approved treatment for a devastating blood disorder called beta-thalassemia.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by